Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Merck & Co., Inc. (MRK)
since 2011 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Merck & Co., Inc..
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 310158.
Total stock buying since 2011: $1,621,756.
Total stock sales since 2011: $768,541,123.
Total stock option exercises since 2011: $307,360,302.
Table 3. Detailed insider trading at Merck & Co., Inc. (MRK) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2022-05-03 | Williams David Michael (EVP,Chief Info&Digital Officer) | Option Ex | 427 | 87.65 | 37,426 |
| 2022-05-03 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 902 | 87.65 | 79,060 |
| 2022-05-01 | Garay Arpa (SVP Human Health Global Mktg.) | Option Ex | 866 | 88.69 | 76,805 |
| 2022-05-01 | Oosthuizen Johannes Jacobus (SVP, U.S. Market) | Option Ex | 866 | 88.69 | 76,805 |
| 2022-05-01 | Klobuchar Michael A (EVP - Chief Strategy Officer) | Option Ex | 866 | 88.69 | 76,805 |
| 2022-05-01 | Litchfield Caroline (EVP & CFO) | Option Ex | 866 | 88.69 | 76,805 |
| 2022-05-01 | Lecointe-cephas Lisa (SVP Chief Ethics & Com Officer) | Option Ex | 640 | 88.69 | 56,761 |
| 2022-05-01 | Li Dean Y (Executive VP & President, MRL) | Option Ex | 1,061 | 88.69 | 94,100 |
| 2022-05-01 | Williams David Michael (EVP,Chief Info&Digital Officer) | Option Ex | 577 | 88.69 | 51,174 |
| 2022-05-01 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 928 | 88.69 | 82,304 |
| 2022-02-10 | Williams David Michael (EVP,Chief Info&Digital Officer) | Option Ex | 1,202 | 76.53 | 91,989 |
| 2021-11-09 | Frazier Kenneth C (Executive Chair) | Sale | 663,881 | 82.72 | 54,918,227 |
| 2021-11-09 | Frazier Kenneth C (Executive Chair) | Option Ex | 663,881 | .00 | 0 |
| 2021-11-04 | Litchfield Caroline (EVP & CFO) | Sale | 18,335 | 91.00 | 1,668,503 |
| 2021-11-04 | Litchfield Caroline (EVP & CFO) | Option Ex | 22,683 | .00 | 0 |
| 2021-11-04 | Deluca Richard R. (EVP&Pres, Merck Animal Heallth) | Sale | 29,782 | 90.40 | 2,692,292 |
| 2021-11-04 | Deluca Richard R. (EVP&Pres, Merck Animal Heallth) | Option Ex | 29,782 | .00 | 0 |
| 2021-11-03 | Karachun Rita A (Sr. VP Fince-Global Controller) | Sale | 25,000 | 88.45 | 2,211,225 |
| 2021-11-03 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 25,000 | .00 | 0 |
| 2021-11-01 | Clyburn Frank (EVP & Pres ? Human Health) | Sale | 39,762 | 87.87 | 3,493,886 |
| 2021-11-01 | Clyburn Frank (EVP & Pres ? Human Health) | Option Ex | 39,762 | .00 | 0 |
| 2021-11-01 | Gerberding Julie L. (EVP, Chief Patient Officer) | Sale | 96,270 | 87.91 | 8,462,710 |
| 2021-11-01 | Gerberding Julie L. (EVP, Chief Patient Officer) | Option Ex | 96,270 | .00 | 0 |
| 2021-10-30 | Clyburn Frank (EVP & Pres ? Human Health) | Option Ex | 2,358 | 88.05 | 207,621 |
| 2021-10-30 | Mizell Steven (EVP, Chief HR Officer) | Option Ex | 4,715 | 88.05 | 415,155 |
| 2021-10-29 | Chattopadhyay Sanat (Exe V-P & Pres. MMD) | Sale | 24,619 | 87.32 | 2,149,731 |
| 2021-10-29 | Chattopadhyay Sanat (Exe V-P & Pres. MMD) | Option Ex | 24,619 | .00 | 0 |
| 2021-10-29 | Deluca Richard R. (EVP&Pres, Merck Animal Heallth) | Sale | 135,405 | 87.56 | 11,856,332 |
| 2021-10-29 | Deluca Richard R. (EVP&Pres, Merck Animal Heallth) | Option Ex | 135,405 | .00 | 0 |
| 2021-05-04 | Litchfield Caroline (EVP & CFO) | Option Ex | 1,039 | 75.98 | 78,943 |
| 2021-05-04 | Lecointe-cephas Lisa (SVP Chief Ethics & Com Officer) | Option Ex | 694 | 75.98 | 52,730 |
| 2021-05-04 | Li Dean Y (Executive VP & President, MRL) | Option Ex | 694 | 75.98 | 52,730 |
| 2021-05-04 | Williams David Michael (EVP,Chief Info&Digital Officer) | Option Ex | 417 | 75.98 | 31,683 |
| 2021-05-04 | Clyburn Frank (EVP, Chief Commercial Officer) | Option Ex | 1,906 | 75.98 | 144,817 |
| 2021-05-04 | Zachary Jennifer (EVP, General Counsel) | Option Ex | 5,772 | 75.98 | 438,556 |
| 2021-05-03 | Lecointe-cephas Lisa (SVP Chief Ethics & Com Officer) | Option Ex | 437 | 74.50 | 32,556 |
| 2021-05-03 | Li Dean Y (Executive VP & President, MRL) | Option Ex | 750 | 74.50 | 55,875 |
| 2021-05-03 | Williams David Michael (EVP,Chief Info&Digital Officer) | Option Ex | 412 | 74.50 | 30,694 |
| 2021-05-03 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 875 | 74.50 | 65,187 |
| 2021-05-01 | Lecointe-cephas Lisa (SVP Chief Ethics & Com Officer) | Option Ex | 622 | 74.50 | 46,339 |
| 2021-05-01 | Li Dean Y (Executive VP & President, MRL) | Option Ex | 1,030 | 74.50 | 76,735 |
| 2021-05-01 | Williams David Michael (EVP,Chief Info&Digital Officer) | Option Ex | 560 | 74.50 | 41,720 |
| 2021-05-01 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 901 | 74.50 | 67,124 |
| 2021-02-10 | Williams David Michael (EVP,Chief Info&Digital Officer) | Option Ex | 1,167 | 75.04 | 87,571 |
| 2020-11-09 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 280,000 | 81.41 | 22,793,680 |
| 2020-10-30 | Clyburn Frank (EVP, Chief Commercial Officer) | Option Ex | 2,287 | 75.89 | 173,560 |
| 2020-10-30 | Nally Michael (EVP, Chief Marketing Officer) | Option Ex | 2,287 | 75.89 | 173,560 |
| 2020-10-30 | Mizell Steven (EVP, Chief HR Officer) | Option Ex | 4,574 | 75.89 | 347,120 |
| 2020-10-05 | Davis Robert M (EVP, Global Svcs & CFO) | Sale | 251,273 | 81.03 | 20,360,399 |
| 2020-10-05 | Davis Robert M (EVP, Global Svcs & CFO) | Option Ex | 251,273 | .00 | 0 |
| 2020-08-13 | Chattopadhyay Sanat (Exe V-P & Pres. MMD) | Sale | 10,380 | 83.01 | 861,674 |
| 2020-08-05 | Clyburn Frank (EVP, Chief Commercial Officer) | Sale | 18,876 | 81.55 | 1,539,281 |
| 2020-08-05 | Clyburn Frank (EVP, Chief Commercial Officer) | Option Ex | 18,876 | .00 | 0 |
| 2020-07-17 | Gerberding Julie L. (EVP Strat Comm, GI Pub Policy) | Sale | 36,285 | 80.00 | 2,902,981 |
| 2020-07-17 | Gerberding Julie L. (EVP Strat Comm, GI Pub Policy) | Option Ex | 18,111 | .00 | 0 |
| 2020-05-07 | Brun Leslie A (Director) | Sale | 5,000 | 75.46 | 377,299 |
| 2020-05-07 | Brun Leslie A (Director) | Option Ex | 5,000 | .00 | 0 |
| 2020-05-07 | Weeks Wendell P (Director) | Sale | 5,000 | 76.02 | 380,105 |
| 2020-05-07 | Weeks Wendell P (Director) | Option Ex | 5,000 | .00 | 0 |
| 2020-05-05 | Fleming Michael (SVP Chief Ethics & Com Officer) | Option Ex | 1,290 | 76.86 | 99,149 |
| 2020-05-05 | Clyburn Frank (EVP, Chief Commercial Officer) | Option Ex | 3,752 | 76.86 | 288,378 |
| 2020-05-05 | Nally Michael (EVP, Chief Marketing Officer) | Option Ex | 2,345 | 76.86 | 180,236 |
| 2020-05-05 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 3,283 | 76.86 | 252,331 |
| 2020-05-04 | Fleming Michael (SVP Chief Ethics & Com Officer) | Option Ex | 692 | 77.67 | 53,747 |
| 2020-05-04 | Clyburn Frank (EVP, Chief Commercial Officer) | Option Ex | 1,904 | 77.67 | 147,883 |
| 2020-05-04 | Nally Michael (EVP, Chief Marketing Officer) | Option Ex | 1,298 | 77.67 | 100,815 |
| 2020-05-04 | Zachary Jennifer (EVP, General Counsel) | Option Ex | 5,772 | 77.67 | 448,311 |
| 2020-05-04 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 1,212 | 77.67 | 94,136 |
| 2020-05-03 | Fleming Michael (SVP Chief Ethics & Com Officer) | Option Ex | 1,541 | 77.67 | 119,689 |
| 2020-05-03 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 875 | 77.67 | 67,961 |
| 2020-01-13 | Gerberding Julie L. (EVP Strat Comm, GI Pub Policy) | Sale | 102,073 | 89.34 | 9,118,895 |
| 2020-01-13 | Gerberding Julie L. (EVP Strat Comm, GI Pub Policy) | Option Ex | 82,548 | .00 | 0 |
| 2019-10-30 | Clyburn Frank (EVP, Chief Commercial Officer) | Option Ex | 2,287 | .00 | 0 |
| 2019-10-30 | Nally Michael (EVP, Chief Marketing Officer) | Option Ex | 2,287 | .00 | 0 |
| 2019-10-30 | Scholefield James H (EVP,Chief Info&Digital Officer) | Option Ex | 11,436 | .00 | 0 |
| 2019-10-30 | Mizell Steven (EVP, Chief HR Officer) | Option Ex | 4,574 | .00 | 0 |
| 2019-08-09 | Deluca Richard R. (EVP&Pres, Merck Animal Heallth) | Sale | 6,427 | 85.09 | 546,847 |
| 2019-08-09 | Deluca Richard R. (EVP&Pres, Merck Animal Heallth) | Option Ex | 6,427 | .00 | 0 |
| 2019-08-08 | Deluca Richard R. (EVP&Pres, Merck Animal Heallth) | Sale | 31,699 | 85.01 | 2,694,795 |
| 2019-08-08 | Deluca Richard R. (EVP&Pres, Merck Animal Heallth) | Option Ex | 31,699 | .00 | 0 |
| 2019-06-25 | Davis Robert M (EVP, Global Svcs & CFO) | Sale | 216,718 | 85.67 | 18,567,314 |
| 2019-06-25 | Davis Robert M (EVP, Global Svcs & CFO) | Option Ex | 216,718 | .00 | 0 |
| 2019-05-10 | Fleming Michael (SVP Chief Ethics & Com Officer) | Option Ex | 1,509 | .00 | 0 |
| 2019-05-10 | Clyburn Frank (EVP, Chief Commercial Officer) | Option Ex | 4,389 | .00 | 0 |
| 2019-05-10 | Nally Michael (EVP, Chief Marketing Officer) | Option Ex | 1,811 | .00 | 0 |
| 2019-05-10 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 3,292 | .00 | 0 |
| 2019-05-07 | Clyburn Frank (EVP, Chief Commercial Officer) | Sale | 25,000 | 77.73 | 1,943,175 |
| 2019-05-07 | Clyburn Frank (EVP, Chief Commercial Officer) | Option Ex | 25,000 | 39.29 | 982,250 |
| 2019-05-04 | Fleming Michael (SVP Chief Ethics & Com Officer) | Option Ex | 692 | .00 | 0 |
| 2019-05-04 | Clyburn Frank (EVP, Chief Commercial Officer) | Option Ex | 1,904 | .00 | 0 |
| 2019-05-04 | Nally Michael (EVP, Chief Marketing Officer) | Option Ex | 1,298 | .00 | 0 |
| 2019-05-04 | Zachary Jennifer (EVP, General Counsel) | Option Ex | 5,772 | .00 | 0 |
| 2019-05-04 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 1,212 | .00 | 0 |
| 2019-05-03 | Deluca Richard R. (EVP&Pres, Merck Animal Heallth) | Sale | 35,000 | 80.00 | 2,800,000 |
| 2019-05-03 | Deluca Richard R. (EVP&Pres, Merck Animal Heallth) | Option Ex | 35,000 | 39.29 | 1,375,150 |
| 2019-03-25 | Davis Robert M (EVP, Global Svcs & CFO) | Sale | 192,572 | 82.38 | 15,863,118 |
| 2019-03-25 | Davis Robert M (EVP, Global Svcs & CFO) | Option Ex | 192,572 | 58.22 | 11,211,541 |
| 2019-03-20 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 192,736 | 82.05 | 15,813,410 |
| 2019-03-20 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 192,736 | 39.29 | 7,572,597 |
| 2019-03-13 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 18,725 | 82.00 | 1,535,450 |
| 2019-03-13 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 18,725 | 39.29 | 735,705 |
| 2019-03-05 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 6,961 | 82.00 | 570,808 |
| 2019-03-05 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 6,961 | 39.29 | 273,497 |
| 2019-03-04 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 13,144 | 82.00 | 1,077,873 |
| 2019-03-04 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 13,144 | 39.29 | 516,427 |
| 2019-02-22 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 53,961 | 80.02 | 4,318,067 |
| 2019-02-22 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 53,961 | 39.29 | 2,120,127 |
| 2019-02-21 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 41,992 | 80.00 | 3,359,443 |
| 2019-02-21 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 41,992 | 39.29 | 1,649,865 |
| 2019-02-19 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 42,700 | 80.02 | 3,416,939 |
| 2019-02-19 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 42,700 | 39.29 | 1,677,683 |
| 2019-02-15 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 92,913 | 80.03 | 7,436,199 |
| 2019-02-15 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 92,913 | 39.29 | 3,650,551 |
| 2019-02-14 | Karachun Rita A (Sr. VP Fince-Global Controller) | Sale | 64,662 | 78.96 | 5,105,970 |
| 2019-02-14 | Karachun Rita A (Sr. VP Fince-Global Controller) | Option Ex | 64,662 | 59.04 | 3,817,644 |
| 2019-02-13 | Weeks Wendell P (Director) | Sale | 5,000 | 78.71 | 393,549 |
| 2019-02-13 | Weeks Wendell P (Director) | Option Ex | 5,000 | 24.30 | 121,500 |
| 2019-02-12 | Chattopadhyay Sanat (Exe V-P & Pres. MMD) | Sale | 73,727 | 78.62 | 5,796,343 |
| 2019-02-12 | Chattopadhyay Sanat (Exe V-P & Pres. MMD) | Option Ex | 73,727 | 37.92 | 2,796,096 |
| 2019-02-08 | Brun Leslie A (Director) | Sale | 3,052 | 77.22 | 235,681 |
| 2019-02-08 | Brun Leslie A (Director) | Option Ex | 5,000 | 24.30 | 121,500 |
| 2019-02-05 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 231,566 | 78.08 | 18,079,747 |
| 2019-02-05 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 231,566 | 39.29 | 9,098,228 |
| 2019-02-04 | Glocer Thomas H (Director) | Sale | 10,000 | 75.96 | 759,590 |
| 2019-02-04 | Glocer Thomas H (Director) | Option Ex | 10,000 | 29.75 | 297,450 |
| 2018-11-08 | Perlmutter Roger M (Exe V-P & Pres, MRL) | Sale | 225,443 | 75.27 | 16,967,967 |
| 2018-11-08 | Perlmutter Roger M (Exe V-P & Pres, MRL) | Option Ex | 225,443 | 44.98 | 10,140,426 |
| 2018-11-07 | Gerberding Julie L. (EVP Strat Comm, Gl Pub Policy) | Sale | 36,218 | 75.14 | 2,721,348 |
| 2018-11-07 | Gerberding Julie L. (EVP Strat Comm, Gl Pub Policy) | Option Ex | 36,218 | 54.68 | 1,980,400 |
| 2018-11-01 | Schechter Adam H (EVP & Pres-Global Human Health) | Sale | 277,879 | 73.82 | 20,512,749 |
| 2018-11-01 | Schechter Adam H (EVP & Pres-Global Human Health) | Option Ex | 277,879 | 39.29 | 10,917,865 |
| 2018-10-31 | Watson Ashley (SVP Chief Ethics & Com Officer) | Sale | 47,036 | 74.33 | 3,496,138 |
| 2018-10-31 | Watson Ashley (SVP Chief Ethics & Com Officer) | Option Ex | 47,036 | 59.50 | 2,798,783 |
| 2018-10-30 | Deluca Richard R. (EVP&Pres, Merck Animal Health) | Sale | 25,467 | 72.00 | 1,833,751 |
| 2018-10-30 | Deluca Richard R. (EVP&Pres, Merck Animal Health) | Option Ex | 25,467 | 34.19 | 870,716 |
| 2018-10-02 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 279,850 | 72.07 | 20,168,229 |
| 2018-10-02 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 279,850 | 36.56 | 10,231,316 |
| 2018-09-18 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 279,851 | 70.08 | 19,611,958 |
| 2018-09-18 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 279,851 | 36.56 | 10,231,352 |
| 2018-09-17 | Schechter Adam H (EVP & Pres-Global Human Health) | Sale | 107,360 | 70.18 | 7,534,310 |
| 2018-09-17 | Schechter Adam H (EVP & Pres-Global Human Health) | Option Ex | 100,000 | 36.56 | 3,656,000 |
| 2018-08-03 | Chattopadhyay Sanat (Exe V-P & Pres. MMD) | Sale | 29,208 | 65.20 | 1,904,361 |
| 2018-08-03 | Chattopadhyay Sanat (Exe V-P & Pres. MMD) | Option Ex | 29,208 | 35.49 | 1,036,591 |
| 2018-08-02 | Karachun Rita A (Sr. VP Fince-Global Controller) | Sale | 5,000 | 65.01 | 325,040 |
| 2018-07-31 | Frazier Kenneth C (Chairman, President & CEO) | Sale | 228,091 | 65.00 | 14,826,599 |
| 2018-07-31 | Frazier Kenneth C (Chairman, President & CEO) | Option Ex | 228,091 | 33.49 | 7,638,767 |
| 2018-06-18 | Schechter Adam H (EVP & Pres-Global Human Health) | Sale | 134,094 | 61.00 | 8,180,002 |
| 2018-06-18 | Schechter Adam H (EVP & Pres-Global Human Health) | Option Ex | 100,000 | 36.56 | 3,656,000 |
| 2018-05-15 | Gerberding Julie L. (EVP Strat Comm, Gl Pub Policy) | Sale | 9,972 | 59.66 | 594,959 |
| 2018-05-01 | Watson Ashley (SVP Chief Ethics & Com Officer) | Option Ex | 10,441 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
of MRK listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Merck & Co., Inc. (symbol MRK,
CIK number 310158) see
the Securities and Exchange Commission (SEC) website.